Protective dressing for skin-placed medical device

Information

  • Patent Grant
  • 10456497
  • Patent Number
    10,456,497
  • Date Filed
    Thursday, September 10, 2015
    9 years ago
  • Date Issued
    Tuesday, October 29, 2019
    4 years ago
Abstract
A dressing for use in protectively covering and isolating a medical device placed on and/or through the skin surface of a patient is disclosed. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. In one embodiment, a dressing for covering a medical device on a skin surface of a patient is disclosed and comprises a dressing portion that is configured to rest against a skin surface of a patient, with the dressing portion defining a hole, and a polymeric cover film that is at least indirectly attached to the dressing portion. The cover film includes a pliable domed portion aligned with the hole of the dressing portion. The pliable domed portion defines a cavity that is configured to receive therein the medical device when the dressing is placed on the skin of the patient.
Description
BRIEF SUMMARY

Briefly summarized, embodiments of the present invention are directed to a dressing for use in protectively covering a medical device placed on and/or through the skin surface of a patient. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. When placed atop the skin-placed medical device, the dressing prevents bacteria and other undesired microbes or external contaminants from reaching the medical device and its insertion site through the skin. Further, the dressing is configured such that water vapor may be transmitted therethrough, thus enabling the insertion site to breathe and prevent undesired moisture buildup under the dressing.


In one embodiment, a dressing for covering a medical device on a skin surface of a patient is disclosed and comprises a dressing portion that is configured to rest against a skin surface of a patient, with the dressing portion defining a hole, and a polymeric cover film that is at least indirectly attached to the dressing portion. The cover film includes a pliable domed portion aligned with the hole of the dressing portion. The pliable domed portion defines a cavity that configured to receive therein the medical device when the dressing is placed on the skin of the patient.


These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIGS. 1A and 1B are various views of a medical device dressing according to one embodiment;



FIG. 2 is a perspective view of a medical device dressing in place atop a medical device according to one embodiment;



FIG. 3 is a perspective view of a portion of a medical device and a dressing according to one embodiment;



FIGS. 4A and 4B are various views of a medical device dressing according to one embodiment;



FIG. 5 shows various views of a plurality of molds used in forming a medical device dressing according to one embodiment;



FIGS. 6A-6D are various views of a medical device dressing according to one embodiment;



FIG. 7 is an exploded view of the medical device dressing of FIGS. 6A-6D;



FIGS. 8A and 8B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 9A and 9B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 10A and 10B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 11A and 11B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 12A and 12B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 13A and 13B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 14A and 14B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 15A and 15B show various views of a portion of the medical device dressing of FIGS. 6A-6D;



FIG. 16 is a top view of a portion of the medical device dressing of FIGS. 6A-6D;



FIGS. 17A-17D show various views depicting placement of the medical device dressing of FIGS. 6A-6D on a skin surface of a patient; and



FIGS. 18A and 18B are various views of a medical device dressing according to one embodiment.





DETAILED DESCRIPTION OF SELECTED EMBODIMENTS

Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.


For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”


Embodiments of the present invention are generally directed to a dressing for use in protectively covering a medical device placed on and/or through the skin surface of a patient. Examples of such devices include infusion needles for accessing subcutaneously implanted access ports, catheters of various types and purposes, insulin infusion needles, etc. When placed atop the skin-placed medical device, the dressing prevents bacteria and other undesired microbes or external contaminants from reaching the medical device and its insertion site through the skin. Further, the dressing is configured such that water vapor may be transmitted therethrough, thus enabling the insertion site to breathe and prevent undesired moisture buildup under the dressing.


In accordance with one embodiment, the dressing is shaped and configured so as to suitably cover medical devices that extend some distance above the skin surface without causing deformation, “tenting,” and/or peel-away of the dressing from the skin due to tension between the dressing surface and the medical device. In addition, the dressing includes a pliable domed cover that can cover the medical device, conform to the medical device if necessary, and deform when contacted so as to enhance patient comfort, all while providing isolation for the medical device from potential contaminants. In one embodiment, the domed cover also assists in securing the medical device in place on the patient skin.


Reference is first made to FIGS. 1A and 1B, which show various views of a dressing for a medical device (“dressing”), generally designated at 10, according to one embodiment. As shown, the dressing 10 includes a body 12 that in turn includes a perimeter portion 14 surrounding a central portion 16. The perimeter portion 14 provides a barrier and boundary for the dressing 10 by adhering to the skin of the patient about a medical device placed on the skin or through the skin via an insertion site. As such, the perimeter portion 14 includes in the present embodiment an adhesive 20 on its bottom, skin-contacting surface so as to easily adhere to the skin surface when placed by a clinician over a medical device. In another embodiment, the dressing 10 can be attached to the skin without covering a medical device, such as in the case of covering a wound, incision, etc.


In the present embodiment, the perimeter portion 14 includes a suitably strong yet bendable material such as a non-woven fabric including polyester or other suitable material. Though shown as circular, the shape of the perimeter portion 14 can include other shapes, such as square, oval, triangular, etc.


The dressing 10 further includes a central portion 16 that is pliable and breathable so as to enable moisture transfer therethrough and prevent undesired moisture buildup underneath the dressing 10. As such, in the present embodiment the central portion 16 includes polyurethane or other suitable thermoplastic or material that possesses a relatively high moisture vapor transfer rate (“mvtr”) so as to enable suitable moisture transmission therethrough. In one embodiment, a polyurethane sheet with a thickness of between about 0.8 mil to about 2 mils is employed for the central portion 16, though it is appreciated that other sheet thicknesses of differing moisture vapor transfer rates can be employed, including low mvtr values.


In the present embodiment, the central portion 16 is suitably transparent to enable inspection of the medical device/insertion site under the dressing 10 to be made from outside the dressing. Use of a polyurethane central portion provides such transparency, as do other suitable thermoplastics. In another embodiment, the central portion 16 is semi-transparent or opaque.



FIGS. 1A and 1B further show that the central portion 16 of the dressing 10 includes a pliable, domed portion 18 that is raised with respect to the surrounding portions of the dressing. The raised nature of the domed portion 18 defines a cavity 24 under the domed portion that can be occupied by the infusion needle or other medical device when the dressing 10 is placed over the device. This enables the dressing 10 to suitably cover and isolate the infusion needle disposed beneath the central portion 16 without significant, undesired deformation of the dressing, which is common in known dressings. Such undesired deformation of the dressing includes “tenting,” in which the dressing is deformed into a pointed or spiked configuration, which causes a separation force that can result in the pulling away of the perimeter of the adhesively adhered dressing from engagement with the skin, thus possibly compromising the isolating nature of the dressing and providing an undesired entry pathway for microbes into the dressing interior. Tenting is thus an example of undesired dressing deformations that are prevented by virtue of the three-dimensionally raised nature of the domed portion 18 of the present dressing 10.


Because it is manufactured from the pliable material of the central portion 16, the domed portion 18, though given a raised configuration so as to extend away from the patient skins, is collapsible in this and other embodiments as to increase patient comfort.


As part of the central portion 16, the domed portion 18 in the present embodiment includes the same material as the central portion (such as polyurethane), though in other embodiments the domed portion can include a material that differs from other portions of the dressing 10, including the central portion. Further, in the present embodiment the underside of the regions of the central portion 16 that surround the domed portion include the adhesive 20 (as does the underside of the perimeter portion 14) so as to adhere to the skin when the dressing 10 is placed thereon, while the domed portion 18 includes no such adhesive so it can remain raised from the skin surface and not interfere with the medical device. In other embodiments, the configuration of adhesive application can vary, such as the application of adhesive to the underside of the domed portion 18 so as to adhere the domed portion to the medical device it covers. It is also appreciated that one or more antimicrobial agents can be applied to the underside or other suitable portions of the dressing so as to prevent the formation of microbes. In one embodiment, the antimicrobial agent can include silver, chlorhexidine gluconate (“CHG”), isopropyl alcohol (“IPA”), etc. Further details regarding antimicrobial agents that may be used according to one embodiment are found in U. S. Patent Application Publication No. 2013/0110025, filed Jul. 4, 2011, and entitled “Dressing Device for Use with a Cannula or a Catheter,” which is incorporated herein by reference in its entirety.


As seen in FIGS. 1A and 1B, the domed portion 18 is shaped in one embodiment to correspond to the shape of a medical device, such as a particular infusion set, that is placed on the skin to be covered by the dressing 10. In the illustrated embodiment, for instance, the domed portion 18 includes indentations 26 to conform to a particular shape of an infusion set having a raised central hub. It is appreciated that the particular size, shape, and other configuration of the domed portion 18 can vary from what is shown and described herein. Further, the domed portion can be shaped to define a hemispherical cavity or other three-dimensional volume, including square, triangular, oval, oblong, and various other geometric and non-geometric shapes. As such, the term “domed portion” is understood to include a variety of shapes as formed by the pliable material of the central portion of the dressing, described above.



FIGS. 1A and 1B further show that the dressing 10 includes release liners 22 that protect the adhesive underside of the dressing and that are removed by the user before placing the dressing on the patient's skin. The domed portion 18 further defines a convergence, or point 28, in the present embodiment. The point 28 provides a visual cue for the clinician so as to place the dressing at a desired orientation on the skin of the patient. The point 28 further gives the dome portion a teardrop-shaped perimeter, in one embodiment. In the present embodiment, for instance, the point 28 corresponds with the direction of extension of the infusion set tubing from the infusion set. The tubing can then extend under the perimeter portion 14 where the adhesive on the underside of the perimeter portion seals about the tubing to isolate the cavity 24 of the domed portion 18.



FIG. 2 shows a dressing 10 according to one embodiment, in place atop a medical device that in turn is placed atop a skin surface of a patient. The medical device on the illustrated embodiment is a ported IV catheter 40, though many other medical devices could be used with the dressing 10. As shown and because of its raised domed portion 18, the central portion 16 of the dressing 18 does not undesirably tent up so as to pull the perimeter portion 14 away from the skin 30 of the patient. Note that the tubing 42 of the catheter 40 is aligned with the point 28 of the domed portion 18 to further prevent undesired tenting of the central portion 16. Note also that the size, shape, color, placement, and other configuration aspects of the dressing can vary from what is shown and described herein while still residing within the principles of the present disclosure.


It is appreciated that the shape, size, and configuration of the domed portion 18 of the dressing 10 and other dressing described herein can be modified as needed to cover differing types and sizes of infusion needles, catheters, infusion pumps, and other medical devices. As such, each domed portion can be uniquely shaped to fit over the corresponding infusion set/medical device. In another embodiment, the domed portion is universally sized to fit a variety of infusion needles or other medical devices. Of course, the particular shapes and sizes of the domed portion 18 can vary from what is shown and described herein. In yet another embodiment, the dressing can include more than one domed portion to cover multiple medical devices placed on the patient's skin.



FIG. 3 depicts a dressing 50 according to one embodiment, including a pliable, film-like body 52 including polyurethane or other suitable material, and a foam pad 54 disposed atop the body. In the present embodiment, the foam pad 54 is attached to the top surface of the dressing body 52 via adhesive or the like. The foam pad 54 can carry an antimicrobial substance, such as CHA, IPA, etc. An infusion needle assembly 32 is shown with a needle 34 thereof penetrating the foam pad 54 and body 52 of the dressing 50 when the dressing has been placed on the patient skin prior to insertion of the infusion needle. The dressing 50 thus covers and protects the skin insertion site of the needle 36 of the infusion needle assembly 32.



FIGS. 4A and 4B depict a dressing 110 according to another embodiment, including a body 112 that in turn includes a perimeter portion 114 and a central portion 116. The central portion 116 includes a domed portion 118 shaped to provide an interior cavity for covering a skin-placed medical device. The perimeter portion 114 includes a polyurethane or other suitable film 119 coupled to and atop a substantially flat, non-woven or other suitable material 121 to provide sturdiness to the dressing. An adhesive is applied to an underside of the material 121 so as to enable the dressing 110 to adhere to the skin. A slit 122 is provided to enable tubing or similar component to extend out of the dressing 110.


The domed portion 118 is separately formed with respect to the perimeter portion 114 in the present embodiment, is pliable, and includes a lip 118A to enable it to be secured via adhesive or other fixation within a hole defined in the perimeter portion 114. The domed portion 118 can include shape features 123 that provide some rigidity and/or reinforcement thereto. Note that, despite its name, the central portion in this and other embodiments can be placed in a non-centered location with respect to the dressing body.


In one embodiment, it is appreciated that one or more reinforcement features can extend across the domed portion of the dressings described herein to provide some rigidity and/or reinforcement thereto. The reinforcement feature can include, for instance, an adhesive strip, non-woven material that is bonded to the domed portion 218, etc.


Reference is now made to FIGS. 6A-7, which depict a dressing 210 according to another embodiment. As shown, the dressing 210 including a body 212 that in turn includes a perimeter portion 214 and a central portion 216. The central portion 216 includes a domed portion 218 shaped to define an interior cavity 224 for covering a skin-placed medical device. As best seen in FIG. 6B, the domed portion includes a point 228 for providing adequate space in the cavity 224 for an infusion needle assembly or other medical device to be disposed therein and to assist in indicating to the clinician in which direction the tubing of the infusion needle assembly should extend.


In the present embodiment, the dressing 210 includes a plurality of layers as will be further described below. As seen in FIGS. 6C and 7, 8A, and 8B, a release liner 250 is included on the bottom of the dressing 210 (from the perspective shown in FIG. 7) that prevents undesired adhesion of the dressing to another surface prior to placement thereof on the skin of the patient. The release liner 250 in the present embodiment includes a super-calendered 50 weight craft paper with a silicone coating thereon, though other suitable materials can also be acceptably used, including other papers, polymeric materials, etc.


The release liner 250 includes a hole 270 defining a shape corresponding to domed portion 218. A first notch 271 is included at the side edge of the release liner 250, while a second notch 272 is included in the release liner proximate the portion of the hole 270 corresponding to the point 228 of the domed portion 218. Generally, the shape of the release liner 250 and the position and configuration of the above-named aspects of the release liner are supportive of other dressing components, as discussed below.


A dressing portion 252 is included to serve as a base for the dressing 210 when placed on the skin of the patient and to provide a skin-based barrier to protect the insertion site of the infusion needle or other medical device to be covered by the dressing. As seen in FIGS. 7, 9A, and 9B, the dressing 252 includes a flat, flexible body that defines a hole 280, which is aligned with, and defines a perimeter that corresponds with, both the hole 270 of the release liner 250 and the domed portion 218. A notch 282 is included and corresponds in position with the second notch 272 of the release liner 250. The dressing also defines flat sides 284, though it is appreciated that the dressing portion 252 can include any one of a variety of shapes and sizes to accommodate a variety of dressing applications.


In the present embodiment, the dressing portion 252 includes a non-woven, spunlace polyester material, though it is appreciated that various other materials can be acceptably used. For instance, a knitted polyester could be employed. Desired characteristics for the dressing material include one that can suitably carry the adhesives disposed thereon (discussed below), offers suitable tensile and general strength for retaining the infusion needle assembly and its tubing without tearing and for supporting the domed portion 218, and suitably prevents rolling of the cover film, discussed below.


The bottom surface of the dressing portion 252 includes an adhesive configured to bond the dressing portion to the skin of the patient when the dressing 210 is placed. Though various biocompatible adhesives may be used, in the present embodiment an acrylic adhesive, such as LOCTITE® 737NA acrylic adhesive, is employed for the bottom surface of the dressing portion 252. Other possible adhesives include silicone-based, urethane-based, and hydrocolloid adhesives.


A cover film 254 is included atop the dressing portion 252 to provide a cover for the infusion needle assembly or other skin-placed medical device to be covered by the dressing 210. As seen in FIGS. 7, 10A, and 10B, the cover film 254 includes a flexible body that defines a flat perimeter about the domed portion 218, which is also defined by the cover film. The cover film 254 defines a notch 292 that corresponds in position with both the notch 282 of the dressing portion 252 and the second notch 272 of the release liner 250. The notch 292, together with the notch 282, provides an exit site for the tubing of an infusion needle assembly or other medical device covered by the dressing 210, as will be seen. Like the dressing portion 252, the cover film 254 includes flat sides 294, which correspond with the flat sides 284 of the dressing portion 252, though it is appreciated that the cover film 254 can include any one of a variety of shapes and sizes to accommodate a variety of dressing applications.


In greater detail and as has been described in connection with other embodiments, the pliable domed portion 218 and its point 228 are defined by a raised central portion of the otherwise flat cover film 254 to define the cavity 224 for protecting and isolating the skin-placed medical device, though it is appreciated that the domed portion could be located in other positions on the dressing 210 as well. The particular size, shape, and configuration of the domed portion 218 can vary from what is shown and described herein. The domed portion 218 illustrated in FIGS. 7, 10A, and 10B, for instance, is configured to cover various types of skin-placed infusion needle assemblies. The pliable nature of the domed portion 218 enables it to be collapsed during packaging and before use, then easily expanded up to define the cavity 224 when the dressing 210 is ready to be placed atop the medical device on the skin surface of the patient.


In the present embodiment, the cover film 254 includes a thermoplastic polyurethane film, such as ARGOMEDPLUS® 18411 polyurethane material available from Argotec LLC of Greenfield, Mass., though other suitable materials, including other polymeric materials, could be utilized. Desired characteristics of the material for film cover 254 in one embodiment include: suitably high resilience to deformation/elongation; sufficient vapor transmissiveness; and abrasion, puncture and tear resistance. The thickness of the thermoplastic polyurethane film to be used in manufacturing the cover film 254 is about 2.25 mils, in one embodiment, though the thickness can vary according to the material selected. In another embodiment, the thickness of the thermoplastic polyurethane film is from about 1.5 to about 2.5 mils.


The use of polyurethane as the cover film material enables the domed portion 218 to be pliable while retaining sufficient strength to form its dome shape. Further, the above-described thicknesses of the polyurethane cover film material enables the dome portion 218 to retain a desired moisture vapor transfer rate therethrough. This in turn prevents undesired moisture buildup within the cavity 224 of the domed portion 218 during use of the dressing 210 on the skin surface of the patient. The domed portion 218, together with the other portions of the dressing 210 cooperate to isolate the skin-placed medical device over which the dressing is disposed so as to prevent the incursion of microbes into the cavity 224 of the domed portion, thus preventing infection/compromise of the insertion site of the medical device through the skin of the patient.


An acrylic adhesive or other suitable adhesive is employed between the top surface of the dressing 252 and the bottom surface of the cover film 254 (from the perspective shown in FIG. 7) so as to prevent separation of the two components.


A support frame 256 is included to provide stiffness before and during placement of the dressing 210 over the skin-placed medical device and the skin of the patient. As seen in FIGS. 6, 11A, and 11B, the support frame 256 includes a flat, flexible body that includes a hole 300 such that the body generally defines a horseshoe shape. A cutout 302 is included to enable application of a securement component to the dressing 210 during dressing application. Cutouts 304 are also included on a first support portion 306 of the support frame 256 to help enable removal of a securement component, such as a tube securement assembly 260, which is mounted thereon, as will be described further below. A second support portion 308 is also included on the support frame 256 to provide a mounting surface for a tape strip 264, a date/time strip 262, and/or other component of the dressing 210, as will be seen further below.


A slit 310 is provided on the second support portion 308 to assist in removal of the afore-mentioned tape strip 264, as will be seen. Also, a hole 312 is included adjacent the date/time strip 262 to assist with removal of the date/time strip from the support frame 256, as will be seen. Similar holes can be positioned at other locations on the support frame to assist with the removal of other components removably attached to the support frame, in other embodiments. In yet another embodiment, slits in the support frame can be positioned proximate or under the date/time strip or other removable component so as to promote folding of the support frame and ease removal of the date/time strip from the support frame.


In the present embodiment, the support frame 256 includes a super-calendered kraft paper, though it is appreciated that other materials can also be employed, including polymers including polyethylene, polypropylene, polystyrene, etc. A silicone or other suitable coating is added to the top surface of the support frame 256 in the present embodiment to enable ease of removal of the tube securement assembly 260, date/time strip 262, and the tape strip 264 from the support frame. In the present embodiment, a suitable adhesive, such as a hot-melt adhesive, is applied to permit the attachment of the support frame to the cover film 254 and to permit separation thereof when desired. In one embodiment, the support frame material is pre-attached to the cover film material prior to assembly of the dressing 210. Other suitable support frame adhesives may also be employed.



FIGS. 7, 12A, and 12B show that the tube securement assembly 260 includes a body including a dressing portion 260A and a cover film portion 260B that are adhesively or otherwise joined to one another. In the present embodiment, the dressing portion 260A includes a non-woven, spunlace polyester material similar to that of the dressing portion 252, while the cover film portion 260B includes thermoplastic polyurethane film, such as ARGOMEDPLUS® 18411 polyurethane material, similar to that of the cover film 254. Of course, other suitable materials can be employed. Though various biocompatible adhesives may be used, in the present embodiment an acrylic adhesive, such as LOCTITE® 737NA acrylic adhesive, is included on the bottom surface of the dressing portion 260A of the tube securement assembly 260 to enable it to be applied to the dressing 210 and the skin of the patient, as will be discussed.


A notch 322 is defined in the body of the tube securement assembly 260 and corresponds in position with a corresponding notch on the support frame 256 and the notch 271 on the release liner 250. FIGS. 13A, 13B show that a removable support frame portion 324, including a kraft paper or other suitably stiff material, is applied to a portion of the top surface of the body of the tube securement assembly 260 to provide increased rigidity during placement of the tube securement assembly, discussed below.


The tube securement assembly 260 is removably applied to the top surface of the support frame 256 on the first support portion 306 thereof, as shown in FIG. 6B. Note that the size, shape, and placement of the tube securement assembly can vary from what is shown and described herein.



FIGS. 14A and 14B show that the date/time strip 262—including a non-woven polyester, gauze, fabric, or other suitable material—is removably disposed on the top surface of the support frame 256 on the second support portion 308 thereof, as shown in FIG. 6B. A date/time insignia 328, or other insignia, is disposed on the top surface of the date/time strip 262 to enable data regarding placement of the medical device and/or dressing 210 to be recorded.



FIGS. 15A and 15B show that the elongate adhesive tape strip 264 is removably disposed on the top surface of the support frame 256 on the second support portion 308 thereof, proximate the date/time strip 262, as shown in FIG. 6B. The tape strip 264 can be used to further secure the skin-placed medical device by applying the tape strip over the domed portion 218, to further securing the tubing of the medical device by applying the tape strip over the tube securement assembly 260, to secure the medical device to the skin before placement of the dressing, or to assist in other ways with placement of the dressing 210 on the skin of the patient. Note that the slit 310 included on the support frame 256 (FIGS. 11A, 11B) assists in removing the tape strip 264 from the support frame. In brief, the relatively small portion of the support frame 256 above the slit 310 is ripped off with the tape strip 264 when the tape strip is removed from the support frame, which provides a non-adhesive location on the tape strip to enable the clinician to easily handle the tape strip. Once the tape strip 264 has been placed, the ripped-off portion of the support frame 256 can be removed from the back of the tape strip, and discarded.



FIG. 16 shows that the release liner 250 in the present embodiment includes two extended surfaces, or underhang portions 340, on either end of the dressing 210, which assist the user in grasping and removing the release liner from the rest of the dressing 210 during placement on the skin of the patient. Also shown in FIG. 16 are the two cutouts 304 for assisting the user in grasping and removing the tube securement assembly 260 from the support frame 256. The cutouts 304 are located in an interior position of the dressing 210 as opposed to being located on an outer edge of the dressing, which enables the user to more easily remove the tube securement assembly 260 from the support frame 256 with one hand. Thus, together with the right overhang 340 shown in FIG. 16, the cutouts 304 provide three access points for the user to peel away the tube securement assembly 260 from the support frame 256. Such cutouts can be employed in other areas of the dressing, in other embodiments.


Reference is now made to FIGS. 17A-17D in describing details relating to the placement of the dressing 210 on the skin of the patient over a skin-placed medical device, according to the present embodiment. Note that the dressing 210 in one embodiment is first removed from a sterilized package using suitable sterilization techniques. The release liner 250 is peeled off the back of the dressing 210, using the extended underhang portions 340 (FIG. 16) to help grab the release liner.


Once the release liner 250 has been removed, the dressing 210 is placed over a medical device disposed on the skin of the patient, such as the infusion needle assembly 32 shown in FIG. 17B. The dressing 210 is pressed down so as to be affixed to the skin surface of the patient, taking care to orient the dressing such that the infusion needle assembly 32 is received within the cavity 224 of the teardrop-shaped domed portion 218 and the point 228 of the domed portion is substantially aligned with tubing 34 of the infusion needle assembly and the tubing extends through the notch 282, 292 of the joined dressing portion 252 and cover film 254. The dressing 210 is pressed downward so that the adhesive on the bottom surface of the dressing portion 252 adheres to the skin and around the tubing extending under the dressing portion, noting that no adhesive is present on the domed portion 218. The dressing 210 is secured such that the infusion needle assembly 32 is isolated within the dressing, thus protecting it from contamination, incursion of microbes, etc. In one embodiment, the domed portion of the dressing engages a top portion of the infusion needle assembly or other medical device so as to help maintain the medical device in position on the skin of the patient.


The tube securement assembly 260 is then removed from atop the support frame 256 and placed over the portion of the tubing 34 that extends from the notches 282, 292 so as to overlap both the skin of the patient and the adjacent portion of the dressing 210 and such that the notch 322 receives a portion of the tubing therein, as seen in FIG. 17C. The support frame portion 324 provided added rigidity to help handle and place the tube securement assembly 260 in its desired position. After placement, the support frame portion 324 can be peeled away from the tube securement assembly 260 and discarded. In this way, the tubing 34 is further secured against unintended displacement and is further isolated so as to prevent migration of impurities into the cavity 224 of the domed portion 218 and the infusion needle assembly 32 disposed therein. Further, placement of the tube securement assembly 260 in this manner prevents the tubing 34 from lifting up the edge of the dressing 210 (and thus compromising the isolation of the infusion needle assembly 32) should a pulling force be applied to the tubing. Note that the cutout 302 of the support frame 256 enables the tube securement assembly to be placed on the dressing 210 without first having to remove the support frame.


It is appreciated that in one embodiment the tube securement assembly is integrally formed with the dressing body; in another embodiment, no tube securement assembly is included. The size, shape, configuration, and placement of the tube securement assembly can also vary from what is shown and described herein. In another embodiment the securement assembly is used to secure components other than tubing. For instance, the securement assembly can be used to secure the dressing itself, in one embodiment.


Once the tube securement assembly 260 has been positioned, the support frame can then be removed from the dressing 210, as shown in FIG. 17C, resulting in the dressing placement shown in FIG. 17D. If desired, the date/time strip 262 can be peeled away from the recently-removed support frame 256, using the hole 312 that allows a finger of the user to grasp the bottom surface of the date/time strip. The date/time strip 262 can then be placed on the cover film 254 of the dressing 210, the tube securement assembly 260, or in another suitable location. Also if needed, the tape strip 264 can be removed from the support frame 256 and utilized on the dressing 210, as already described further above.


It is appreciated that, in one embodiment, no support frame is included in the dressing. In such a case, the release liner can optionally be made relatively thicker to provide for the desired stiffness of the dressing.


The dressing 210 is manufactured in one embodiment by first joining the dressing portion 252 to cover film 254. In particular, an adhesive (described further above) is applied to the top surface of the dressing portion 252 and the cover film 254, with the support frame 256 pre-attached thereto, is attached to the dressing portion. At this stage, the domed portion 218 has not yet been defined in the cover film 254.


The dressing portion 252 and joined cover film 254 can be pre-cut to define the respective sides 284, 294, or be cut after being joined together. The release liner 250 can then be joined to the bottom surface of the dressing portion 252. The holes 270, 280 of the respective release liner 250 and dressing portion 252 can be pre-defined or defined after joining of the release liner and the dressing portion. Excess material about the support frame 256 can be removed at this time, in the present embodiment.


The pre-assembled tube securement assembly 260 can be attached to the top surface of the support frame 256, as can the date/time strip 262 and the tape strip 264. Note that, in one embodiment, the final shapes of the tube securement assembly 260, the date/time strip 262, and the tape strip 264 can be defined at this stage via a die cut procedure. In another embodiment, the final shapes of these components can be pre-defined prior to attachment to the support frame 256.


Next, the assembled dressing 210 is electrostatically neutralized via an ionizer to eliminate static electricity before being introduced to a thermal forming process, wherein the dressing is positioned such that the holes 270 and 280 of the release liner 250 and the dressing portion 252 are aligned with a negative-type mold. A vacuum is applied and heat is introduced to the dressing so that the central portion of the cover film 254 is sucked on to and thermally formed about the mold, thus defining the pliable domed portion 218 in the cover film 254. In one embodiment, holes are included in the mold to assist in sucking the cover film on to the mold surface. Note that the release liner 250 acts as a heat shield to protect the dressing portion 252 and the cover film 254 from heat damage during the thermal forming process, in one embodiment. The heat and vacuum are then removed and the dressing 210 is allowed to cool, which causes the domed portion 218 to be permanently defined.


Note that the mold can be a negative or positive form of the desired shape for the domed portion 218. Indeed, FIG. 5 shows various examples of positive molds 70A-70E, each including a shaped body 72. Note also that the shapes of the molds can vary from what is shown and described herein. In one embodiment, a positive air pressure could be employed to force the cover film on to the mold surface.


When forming the domed portion in the above-described manner utilizing a polyurethane cover film 254 of about 2 mils thickness as detailed further above, the thickness of the resultant domed portion 218 is from about 0.65 mil to about 1 mil, in one embodiment.


In other embodiments, other modes for forming the domed portion can be employed, including cold forming (rolling), injection molding, utilizing a pre-formed cover film, and dip casting, in which a form is repeatedly dipped into a molten polyurethane (or other suitable material) and solvent mixture to build up a domed portion cover film. These and other forming techniques are therefore contemplated. It is also appreciated that the above-described manufacturing steps are not exhaustive and that a different order of steps could be employed.



FIGS. 18A and 18B depict a dressing 410 according to one embodiment, including a body 412 defined by a flexible, flat perimeter portion 414 that surrounds a central portion 416 as in previous embodiments. The central portion 416 includes a pliable domed portion 418 of polyurethane or other suitable material.


A releasable portion 416A included about a proximal perimeter of the central portion 416 is configured to be resealable so that access can be selectively made to the PICC 315 or other medical device enclosed within the domed portion 418. A pull-tab 419 or the like is included to facilitate lifting of the proximal portion of the central portion 416. When closed, the releasable portion 416A adheres to a releasable adhesive included on the perimeter portion 414 directly below the releasable portion, indicated in FIGS. 15A and 15B as a release layer portion 414A, so as to maintain isolation of the domed portion 418 when closed.


Correspondingly, an adhered portion 416B is included about a distal perimeter of the central portion 416 and is configured to not separate from attachment with the perimeter portion 414. The adhesive used to secure the adhered portion 416B to the perimeter portion 414 can be the same adhesive as an adhesive 420 that is employed to secure the other portions of the central portion 416 to the perimeter portion 414. The relative sizes, shapes, and extents of both the releasable portion 416A and the adhered portion 416B can be varied from what is shown and described herein. A slit 422 can be included in the perimeter portion 414 to enable removal of the dressing 410 from over the medical device. As in other embodiments, the domed portion 418 can include a notch, or point 428, to fit over a portion of the covered medical device.


Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A dressing for covering a medical device on a skin surface of a patient, comprising: a dressing portion configured to rest against the skin surface of the patient, the dressing portion defining a hole;a polymeric cover film permanently attached to the dressing portion, the polymeric cover film including a pliable domed portion aligned with the hole of the dressing portion, the pliable domed portion defining a cavity configured to receive therein the medical device when the dressing is placed on the skin surface of the patient; anda support frame removably attached to the polymeric cover film to provide rigidity during placement of the dressing on the patient, the support frame including a cutout portion enabling a securement component to be attached to the cover film without removal of the support frame, the securement component removably disposed on a top surface of the support frame before use.
  • 2. The dressing as defined in claim 1, wherein the domed portion is collapsible to enable placement of the dressing in a substantially flat package.
  • 3. The dressing as defined in claim 2, wherein the dome portion is formed via a thermal forming process using a mold.
  • 4. The dressing as defined in claim 3, wherein heat from the thermal forming process is directed through the hole defined in the dressing so as to impinge on the cover film.
  • 5. The dressing as defined in claim 4, wherein the dressing portion includes non-woven polyester and wherein the cover film includes a thermoplastic polyurethane.
  • 6. The dressing as defined in claim 5, further comprising a release liner removably attached to a bottom surface of the dressing portion, the release liner defining a hole aligned with the hole of the dressing portion.
  • 7. The dressing as defined in claim 6, wherein the release liner provides heat shielding for the dressing portion and the cover film during the thermal forming process, and wherein the dome portion prevents tenting of the dressing when the dressing is placed over the medical device on the skin surface of the patient.
  • 8. The dressing as defined in claim 1, wherein the securement component includes a tube securement assembly for securing tubing of the medical device covered by the dressing.
  • 9. The dressing as defined in claim 1, wherein the domed portion is substantially teardrop-shaped.
  • 10. The dressing as defined in claim 1, wherein the cover film includes a thickness proximate an outer perimeter thereof of 2.25 mils, and wherein the domed portion includes a thickness of from 0.65 mil to 1 mil.
  • 11. The dressing as defined in claim 1, wherein the medical device includes an infusion needle assembly.
  • 12. The dressing as defined in claim 11, wherein the cover film and the dressing portion include aligned notches to enable tubing of the medical device to exit the dressing, and wherein a securement component including a notch is placed over the tubing in alignment with the notches of the cover film and the dressing portion.
  • 13. A method of manufacturing a dressing for covering a medical device on a skin surface, the method comprising: providing a dressing portion defining a hole;attaching a polymeric cover film to the dressing portion;forming a pliable domed portion in the polymeric cover film after the polymeric cover film is attached to the dressing portion to align a perimeter of the domed portion with the hole defined in the dressing portion;removably attaching a release liner to a bottom surface of the dressing portion;removably attaching a support frame to a top surface of the polymeric cover film;removably attaching a tube securement assembly to a support portion of the support frame, the support portion including at least one cutout portion to enable a user to easily remove the tube securement assembly from the support frame, the at least one cutout portion disposed inward from an outer perimeter of the support frame.
  • 14. The method of manufacturing as defined in claim 13, wherein attaching the cover film includes attaching the cover film to the dressing portion using an acrylic adhesive.
  • 15. The method of manufacturing as defined in claim 13, wherein forming the pliable domed portion includes thermally forming the pliable domed portion.
  • 16. The method of manufacturing as defined in claim 15, wherein thermally forming the pliable domed portion further comprises: applying a vacuum to force a portion of the cover film into proximity with a mold; andapplying heat to the cover film while the portion of the cover film is in proximity with the mold such that the domed portion is formed.
  • 17. A dressing for covering a medical device on a skin surface of a patient, comprising: a release layer;a dressing portion removably attached to the release layer, the dressing portion configured to rest against the skin surface of the patient, the dressing portion defining a hole having an outer perimeter;a polymeric cover film attached to the dressing portion, the polymeric cover film including a pliable domed portion having a shape corresponding to the outer perimeter of the hole of the dressing portion, the pliable domed portion defining a cavity configured to receive therein the medical device when the dressing is placed on the skin surface of the patient;a support frame removably attached to the polymeric cover film configured to provide rigidity to the dressing; anda securement component removably attached to the support frame, the securement component configured to secure a portion of the medical device, wherein the support frame includes a gap configured to enable the securement component to be removed from the support frame and attached to the polymeric cover film without removing the support frame from the polymeric cover film.
  • 18. The dressing as defined in claim 17, further comprising a tape strip that is removably attached to the support frame.
  • 19. The dressing as defined in claim 18, wherein a slit is included on the support frame beneath the tape strip to enable the tape strip to be readily removed from the support frame.
  • 20. The dressing as defined in claim 17, further comprising a date/time strip that is removably attached to the support frame.
  • 21. The dressing as defined in claim 20, wherein a hole is defined by the support frame proximate the date/time strip to enable the date/time strip to be manually grasped by a user.
  • 22. The dressing as defined in claim 17, wherein the domed portion includes a predetermined moisture vapor transfer rate to enable moisture to escape from the domed portion.
  • 23. The dressing as defined in claim 17, wherein the securement component comprises a tube securement assembly including a dressing portion, a cover film portion, and a removable support frame portion, the tube securement assembly configured to secure tubing of the medical device at an exit point from the dressing.
  • 24. The dressing as defined in claim 17, wherein the polymeric cover film includes a thermoplastic polyurethane including a thickness of from 1.5 mils to 2.5 mils.
  • 25. The dressing as defined in claim 17, wherein the domed portion is transparent and wherein the domed portion includes at least one reinforcement feature configured to provide strength to the domed portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Patent Application No. 62/048,747, filed Sep. 10, 2014, and titled “Protective Dressing For Skin-Placed Medical Device,” which is incorporated herein by reference in its entirety.

US Referenced Citations (414)
Number Name Date Kind
697637 Lee Apr 1902 A
RE24906 Ulrich Dec 1960 E
3389827 Abere et al. Jun 1968 A
3645835 Hodgson Feb 1972 A
3683911 McCormick Aug 1972 A
3782377 Rychlik Jan 1974 A
3824998 Snyder Jul 1974 A
3900026 Wagner Aug 1975 A
4112213 Waldman Sep 1978 A
4181127 Linsky et al. Jan 1980 A
4231369 Sorensen et al. Nov 1980 A
4275721 Olson Jun 1981 A
4310509 Berglund et al. Jan 1982 A
4323557 Rosso et al. Apr 1982 A
4366814 Riedel Jan 1983 A
4372303 Grossmann et al. Feb 1983 A
4373519 Errede et al. Feb 1983 A
4472480 Olson Sep 1984 A
4477325 Osburn Oct 1984 A
4499896 Heinecke Feb 1985 A
4519793 Galindo May 1985 A
4524087 Engel Jun 1985 A
4534762 Heyer Aug 1985 A
4551490 Doyle et al. Nov 1985 A
4565663 Errede et al. Jan 1986 A
4598004 Heinecke Jul 1986 A
4600001 Gilman Jul 1986 A
4614183 McCracken et al. Sep 1986 A
4619253 Anhauser et al. Oct 1986 A
4633863 Filips et al. Jan 1987 A
4667666 Fryslie May 1987 A
4669458 Abraham et al. Jun 1987 A
4675006 Hrushesky Jun 1987 A
4678462 Vaillancourt Jul 1987 A
4693776 Krampe et al. Sep 1987 A
4706662 Thompson Nov 1987 A
4728323 Matson Mar 1988 A
4737410 Kantner Apr 1988 A
4738257 Meyer et al. Apr 1988 A
4769028 Hoffmann et al. Sep 1988 A
4773408 Cilento et al. Sep 1988 A
4830914 Vaillancourt May 1989 A
4867150 Gilbert Sep 1989 A
4867742 Calderon Sep 1989 A
4867748 Samuelsen Sep 1989 A
4898587 Mera Feb 1990 A
4901714 Jensen Feb 1990 A
4909244 Quarfoot et al. Mar 1990 A
4917112 Kalt Apr 1990 A
4917928 Heinecke Apr 1990 A
4917929 Heinecke Apr 1990 A
4919654 Kalt Apr 1990 A
4931282 Asmus et al. Jun 1990 A
4944040 Riedel et al. Jul 1990 A
4948575 Cole et al. Aug 1990 A
4952618 Olsen Aug 1990 A
RE33353 Heinecke Sep 1990 E
4956350 Mosbey Sep 1990 A
4977892 Ewall Dec 1990 A
4988341 Columbus et al. Jan 1991 A
5000172 Ward Mar 1991 A
5009224 Cole Apr 1991 A
5017625 Ansell May 1991 A
5059424 Cartmell et al. Oct 1991 A
5074847 Greenwell et al. Dec 1991 A
5088483 Heinecke Feb 1992 A
5106629 Cartmell et al. Apr 1992 A
5113860 McQuinn May 1992 A
5133821 Jensen Jul 1992 A
5151314 Brown Sep 1992 A
5153040 Faasse, Jr. Oct 1992 A
5156601 Lorenz et al. Oct 1992 A
5160315 Heinecke et al. Nov 1992 A
5197945 Cole et al. Mar 1993 A
5225473 Duan Jul 1993 A
5236421 Becher Aug 1993 A
5244677 Kreckel et al. Sep 1993 A
5250043 Castellana et al. Oct 1993 A
5266371 Sugii et al. Nov 1993 A
5270358 Asmus Dec 1993 A
5276079 Duan et al. Jan 1994 A
5282791 Lipton et al. Feb 1994 A
5308887 Ko et al. May 1994 A
5338490 Dietz et al. Aug 1994 A
5340363 Fabo Aug 1994 A
5344415 DeBusk et al. Sep 1994 A
5356632 Gross et al. Oct 1994 A
5384174 Ward et al. Jan 1995 A
5386835 Elphick et al. Feb 1995 A
5389376 Duan et al. Feb 1995 A
5409472 Rawlings et al. Apr 1995 A
5409966 Duan et al. Apr 1995 A
5413567 Barth et al. May 1995 A
5415642 Shepherd May 1995 A
5423737 Cartmell et al. Jun 1995 A
5437622 Carion Aug 1995 A
5438988 Duan et al. Aug 1995 A
5447492 Cartmell et al. Sep 1995 A
5509915 Hanson et al. Apr 1996 A
5512041 Bogart Apr 1996 A
5520629 Heinecke et al. May 1996 A
5531855 Heinecke et al. Jul 1996 A
5536544 Liegeois Jul 1996 A
5540922 Fabo Jul 1996 A
5556375 Ewall Sep 1996 A
5593395 Martz Jan 1997 A
5603946 Constantine Feb 1997 A
5605546 Wolzinger et al. Feb 1997 A
5616387 Augst et al. Apr 1997 A
5618556 Johns et al. Apr 1997 A
5622711 Chen Apr 1997 A
5633010 Chen May 1997 A
5637080 Geng Jun 1997 A
5639469 Benes et al. Jun 1997 A
5643187 N.ae butted.stoft et al. Jul 1997 A
5653699 Reed et al. Aug 1997 A
5670557 Dietz et al. Sep 1997 A
5674523 Cartmell et al. Oct 1997 A
5674561 Dietz et al. Oct 1997 A
5704905 Jensen et al. Jan 1998 A
5709651 Ward Jan 1998 A
5713842 Kay Feb 1998 A
5714225 Hansen et al. Feb 1998 A
5728071 Watson et al. Mar 1998 A
5733251 Johns Mar 1998 A
5733570 Chen et al. Mar 1998 A
5738642 Heinecke et al. Apr 1998 A
5750134 Scholz et al. May 1998 A
5750136 Scholz et al. May 1998 A
5755681 Plews May 1998 A
5780045 McQuinn et al. Jul 1998 A
5782787 Webster Jul 1998 A
5792089 Penrose et al. Aug 1998 A
5840052 Johns Nov 1998 A
5846214 Makuuchi et al. Dec 1998 A
5846558 Nielsen et al. Dec 1998 A
5849325 Heinecke et al. Dec 1998 A
5853750 Dietz et al. Dec 1998 A
5885254 Matyas Mar 1999 A
5887590 Price Mar 1999 A
D408541 Dunshee et al. Apr 1999 S
5891076 Fabo Apr 1999 A
D409754 Dunshee et al. May 1999 S
D410087 Dunshee et al. May 1999 S
5939339 Delmore et al. Aug 1999 A
5941840 Court et al. Aug 1999 A
5947917 Carte et al. Sep 1999 A
5951505 Gilman et al. Sep 1999 A
5952398 Dietz et al. Sep 1999 A
5968533 Porter et al. Oct 1999 A
5973221 Collyer et al. Oct 1999 A
5976117 Dunshee et al. Nov 1999 A
5985990 Kantner et al. Nov 1999 A
6008429 Ritger Dec 1999 A
6043408 Geng Mar 2000 A
6090076 Lane, Jr. Jul 2000 A
6103369 Lucast et al. Aug 2000 A
D430674 Dunshee et al. Sep 2000 S
6121508 Bischof et al. Sep 2000 A
6124520 Roberts Sep 2000 A
6124521 Roberts Sep 2000 A
6129971 Brandt et al. Oct 2000 A
6139868 Hoffmann Oct 2000 A
6140548 Hansen et al. Oct 2000 A
6149614 Dunshee et al. Nov 2000 A
6168800 Dobos et al. Jan 2001 B1
6169224 Heinecke et al. Jan 2001 B1
6191339 Gueret Feb 2001 B1
6197397 Sher et al. Mar 2001 B1
6198016 Lucast et al. Mar 2001 B1
6210704 Sasaki et al. Apr 2001 B1
6225521 Gueret May 2001 B1
6255552 Cummings et al. Jul 2001 B1
6264976 Heinecke et al. Jul 2001 B1
6302867 Brown, Jr. et al. Oct 2001 B1
6309500 Jensen et al. Oct 2001 B1
D454955 Dunshee et al. Mar 2002 S
6387495 Reeves et al. May 2002 B1
6420622 Johnston et al. Jul 2002 B1
6429154 Trotter Aug 2002 B1
6436432 Heinecke et al. Aug 2002 B2
6461467 Blatchford et al. Oct 2002 B2
6468383 Kundel Oct 2002 B2
6479073 Lucast et al. Nov 2002 B1
6518343 Lucast et al. Feb 2003 B1
D473947 Jacobson Apr 2003 S
6552244 Jacques et al. Apr 2003 B1
D474842 Wolsing et al. May 2003 S
6566575 Stickels et al. May 2003 B1
6566577 Addison et al. May 2003 B1
6607799 Heinecke et al. Aug 2003 B1
D480144 Adams et al. Sep 2003 S
D484601 Griffiths et al. Dec 2003 S
D484602 Griffiths et al. Dec 2003 S
6663584 Griesbach, III et al. Dec 2003 B2
6680113 Lucast et al. Jan 2004 B1
6685682 Heinecke Feb 2004 B1
6727402 Bruss et al. Apr 2004 B1
D492411 Bierman Jun 2004 S
6756102 Galo Jun 2004 B1
6809230 Hancock et al. Oct 2004 B2
6822132 Ahrens et al. Nov 2004 B2
6827707 Wright et al. Dec 2004 B2
6838589 Liedtke et al. Jan 2005 B2
6841715 Roberts Jan 2005 B2
D501559 Shaw et al. Feb 2005 S
6867342 Johnston et al. Mar 2005 B2
D503982 Liedtke et al. Apr 2005 S
6878385 Jensen et al. Apr 2005 B2
6888042 Freeman May 2005 B1
6897348 Malik May 2005 B2
6903151 Lucast et al. Jun 2005 B2
6903243 Burton Jun 2005 B1
6911243 Sher et al. Jun 2005 B2
6927315 Heinecke et al. Aug 2005 B1
D511005 Liedtke et al. Oct 2005 S
6955659 Carter Oct 2005 B1
D512509 Yamasoto et al. Dec 2005 S
6987209 Augustine et al. Jan 2006 B2
6994904 Joseph et al. Feb 2006 B2
6998511 Worthley Feb 2006 B2
7005031 Lucast et al. Feb 2006 B2
D516729 Liedtke et al. Mar 2006 S
7030288 Liedtke et al. Apr 2006 B2
7049479 Cleary et al. May 2006 B2
D524946 Shaw et al. Jul 2006 S
7094944 Faasse, Jr. Aug 2006 B2
7129389 Watson Oct 2006 B1
7135606 Dozier et al. Nov 2006 B1
7182085 Larsen et al. Feb 2007 B1
7182955 Hart et al. Feb 2007 B2
7183454 Rosenberg Feb 2007 B1
D537948 Smith Mar 2007 S
7217853 Kulichikhin et al. May 2007 B2
7223899 Sigurjonsson May 2007 B2
D545440 Jensen Jun 2007 S
7232454 Rousseau Jun 2007 B2
7279177 Looney et al. Oct 2007 B2
7294751 Propp et al. Nov 2007 B2
7294752 Propp Nov 2007 B1
D557424 Knight Dec 2007 S
7304202 Sigurjonsson et al. Dec 2007 B2
7316840 Neculescu et al. Jan 2008 B2
7317134 Faasse, Jr. Jan 2008 B2
7344512 Yamazaki et al. Mar 2008 B2
D572824 Propp Jul 2008 S
D573260 Dunshee Jul 2008 S
7396975 Sigurjonsson et al. Jul 2008 B2
7442849 Heinecke Oct 2008 B2
7531711 Sigurjonsson et al. May 2009 B2
7563941 Lebner et al. Jul 2009 B2
7576256 Bjomberg et al. Aug 2009 B2
7585554 Johnson et al. Sep 2009 B2
D601707 Chouiller Oct 2009 S
7598298 Lewandowski et al. Oct 2009 B2
7615674 Asherman Nov 2009 B2
7624869 Primer Dec 2009 B2
7626070 Propp Dec 2009 B2
7674948 Propp et al. Mar 2010 B2
7691096 Gillis Apr 2010 B2
7723561 Propp May 2010 B2
D620123 Igwebuike Jul 2010 S
7759537 Bishop et al. Jul 2010 B2
7759539 Shaw et al. Jul 2010 B2
7781639 Johnston et al. Aug 2010 B2
7807661 Ylitalo et al. Oct 2010 B2
7812212 Propp et al. Oct 2010 B2
7858838 Holm et al. Dec 2010 B2
7888546 Marcoux et al. Feb 2011 B2
D634423 Heinecke et al. Mar 2011 S
7910790 Johnston et al. Mar 2011 B2
7981087 Gesler, III Jul 2011 B2
7988673 Wright et al. Aug 2011 B2
7994381 Baron et al. Aug 2011 B2
8002113 Cummings Aug 2011 B1
8049057 Propp Nov 2011 B2
8049058 Propp Nov 2011 B2
8053623 Propp Nov 2011 B2
8053624 Propp Nov 2011 B2
8084665 Liedtke et al. Dec 2011 B2
8093445 Sigurjonsson et al. Jan 2012 B2
8110718 Heinecke Feb 2012 B2
8158845 Qin et al. Apr 2012 B2
8173113 Scholz et al. May 2012 B1
8197447 Wright Jun 2012 B2
8212101 Propp Jul 2012 B2
8237009 Siniaguine Aug 2012 B2
8247635 Sigurjonsson et al. Aug 2012 B2
8269059 Wright et al. Sep 2012 B2
D672464 Holm et al. Dec 2012 S
8344201 Madsen et al. Jan 2013 B2
8372051 Scholz et al. Feb 2013 B2
8404921 Lee et al. Mar 2013 B2
D679392 Peterson et al. Apr 2013 S
D679402 Conrad-Vlasak et al. Apr 2013 S
D679403 Heinecke et al. Apr 2013 S
8409157 Haggstrom et al. Apr 2013 B2
8410332 Burton et al. Apr 2013 B2
8450553 Utterberg et al. May 2013 B2
D683858 Smith Jun 2013 S
8486004 Propp Jul 2013 B1
D687555 Peterson et al. Aug 2013 S
D688377 Heinecke et al. Aug 2013 S
8513481 Gergely et al. Aug 2013 B2
D690425 Heinecke et al. Sep 2013 S
8530022 Fabo et al. Sep 2013 B2
D693010 Mosa et al. Nov 2013 S
D695901 Heinecke et al. Dec 2013 S
8604265 Locke et al. Dec 2013 B2
8663171 Tambourgi et al. Mar 2014 B2
8672905 Riesinger Mar 2014 B2
D704343 Inoo et al. May 2014 S
D710017 Mosa et al. Jul 2014 S
8764714 Fabo et al. Jul 2014 B2
D712046 Igwebuike et al. Aug 2014 S
D712549 Igwebuike et al. Sep 2014 S
D712550 Igwebuike et al. Sep 2014 S
8906815 Moore et al. Dec 2014 B2
9000252 Bradford et al. Apr 2015 B2
D729391 Igwebuike et al. May 2015 S
9029625 Effing et al. May 2015 B2
9168180 Ha Oct 2015 B2
20010027285 Heinecke et al. Oct 2001 A1
20010031370 Kundel Oct 2001 A1
20010051178 Blatchford et al. Dec 2001 A1
20020082540 Johnston et al. Jun 2002 A1
20020128578 Johnston et al. Sep 2002 A1
20030007999 Blatchford et al. Jan 2003 A1
20030125680 Ding Jul 2003 A1
20040133143 Burton et al. Jul 2004 A1
20040143220 Worthley Jul 2004 A1
20040158209 Wright Aug 2004 A1
20040247654 Asmus et al. Dec 2004 A1
20040247655 Asmus et al. Dec 2004 A1
20050080372 Nielsen et al. Apr 2005 A1
20050228352 Heinecke et al. Oct 2005 A1
20060003133 Johnson Jan 2006 A1
20060064049 Marcussen Mar 2006 A1
20070027423 Scheinberg Feb 2007 A1
20070060892 Propp Mar 2007 A1
20070073211 Propp Mar 2007 A1
20070078400 Gesler Apr 2007 A1
20070106265 Gillis May 2007 A1
20070156075 Heinecke Jul 2007 A1
20070179419 Simpson Aug 2007 A1
20080058692 Propp et al. Mar 2008 A1
20080063695 Vitaris Mar 2008 A1
20080132821 Propp et al. Jun 2008 A1
20080281245 Effing et al. Nov 2008 A1
20080312574 Pernot Dec 2008 A1
20090082710 Vitaris Mar 2009 A1
20090187130 Asmus et al. Jul 2009 A1
20090192470 Propp Jul 2009 A1
20090247965 Williams Oct 2009 A1
20100004680 Propp Jan 2010 A1
20100106113 Heinecke Apr 2010 A1
20100106114 Weston Apr 2010 A1
20100121282 Propp May 2010 A1
20100159192 Cotton Jun 2010 A1
20100160866 Propp Jun 2010 A1
20100198161 Propp Aug 2010 A1
20100198162 Propp Aug 2010 A1
20100318013 Fabo et al. Dec 2010 A1
20100318052 Ha et al. Dec 2010 A1
20100318072 Johnston et al. Dec 2010 A1
20110004139 Pigg Jan 2011 A1
20110015556 Fabo et al. Jan 2011 A1
20110052665 Hardy et al. Mar 2011 A1
20110098622 Hatanaka et al. Apr 2011 A1
20110130738 Schmidt Jun 2011 A1
20110166492 Holm et al. Jul 2011 A1
20110257574 Svensby Oct 2011 A1
20110280926 Junginger Nov 2011 A1
20110282292 Polowy et al. Nov 2011 A1
20120010572 Bennett Jan 2012 A1
20120083723 Vitaris et al. Apr 2012 A1
20120109069 Dickert et al. May 2012 A1
20120109070 Elsamahy et al. May 2012 A1
20120150122 Harper Jun 2012 A1
20120197206 Glenn Aug 2012 A1
20120238932 Atteia et al. Sep 2012 A1
20130018322 Wright Jan 2013 A1
20130053747 Lin Feb 2013 A1
20130102945 Long Apr 2013 A1
20130138063 Wiltshire et al. May 2013 A1
20130150796 Souza et al. Jun 2013 A1
20130152944 Okada et al. Jun 2013 A1
20130165865 Kelvered et al. Jun 2013 A1
20130172843 Kurata Jul 2013 A1
20130211347 Arbel et al. Aug 2013 A1
20130218085 Knobloch Aug 2013 A1
20130220347 Al Otaibi Aug 2013 A1
20130281906 Fabo et al. Oct 2013 A1
20130310754 Kutsch Nov 2013 A1
20130317405 Ha et al. Nov 2013 A1
20130317406 Locke et al. Nov 2013 A1
20140005607 Elsamahy et al. Jan 2014 A1
20140058309 Addison et al. Feb 2014 A1
20140066867 Locke et al. Mar 2014 A1
20140107561 Dorian et al. Apr 2014 A1
20140121638 Mosa et al. May 2014 A1
20140121649 Calco May 2014 A1
20140142490 Johannison May 2014 A1
20140142526 Auguste et al. May 2014 A1
20140158572 Jensen Jun 2014 A1
20140243728 Igwebuike et al. Aug 2014 A1
20140249495 Mumby et al. Sep 2014 A1
20140257242 Sung Sep 2014 A1
20140316353 Riesinger Oct 2014 A1
20150005688 Goby Jan 2015 A1
20150088085 Rovaniemi Mar 2015 A1
20150141949 Decabooter et al. May 2015 A1
20150157509 Atkinson et al. Jun 2015 A1
20150209188 Scheremet et al. Jul 2015 A1
Foreign Referenced Citations (40)
Number Date Country
5193 Nov 1979 EP
368541 May 1990 EP
424165 Apr 1991 EP
919211 Jun 1999 EP
1457164 Dec 1976 GB
1984003837 Oct 1984 WO
1992016245 Oct 1992 WO
1994012134 Jun 1994 WO
1994021207 Sep 1994 WO
1998000080 Jan 1998 WO
1998015245 Apr 1998 WO
1999006077 Feb 1999 WO
1999027975 Jun 1999 WO
0149233 Jul 2001 WO
0220067 Mar 2002 WO
0234304 May 2002 WO
0380133 Oct 2003 WO
2004026389 Apr 2004 WO
2007034393 Mar 2007 WO
2009075636 Jun 2009 WO
2012083965 Jun 2012 WO
2012125530 Sep 2012 WO
2013057508 Apr 2013 WO
2013082883 Jun 2013 WO
2013096027 Jun 2013 WO
2013162680 Oct 2013 WO
2013173588 Nov 2013 WO
2014020440 Feb 2014 WO
2014020443 Feb 2014 WO
2014051040 Apr 2014 WO
2014081626 May 2014 WO
2014097069 Jun 2014 WO
2014099709 Jun 2014 WO
2014120746 Aug 2014 WO
2015022334 Feb 2015 WO
2015022340 Feb 2015 WO
2015050749 Apr 2015 WO
2015102981 Jul 2015 WO
2015130608 Sep 2015 WO
2016040695 Mar 2016 WO
Non-Patent Literature Citations (18)
Entry
US 7,390,501 B2, 06/2008, Hart et al. (withdrawn)
3M “3M Tegaderm and Tegaderm HP Transparent Dressings” 2005.
3M “3M Tegaderm IV Advanced Securement Dressings”, (1 of 2) 2011.
3M “3M Tegaderm IV Advanced Securement Dressings”, (2 of 2) 2011.
3M “Tegaderm Full Line of IV Site Dressings” brochure. 2012.
3M Tegaderm Transparent Dressing—2-3/8x2-3/4in., 2013.
3M Tegaderm Transparent Dressing—4x4,3/4in., 2013.
3M Tegaderm Transparent Dressing—6x8in., 2013.
3M Tegaderm Transparent Dressing—Film Roll, 2005.
3M Tegaderm Transparent Dressing—Notched 4x4,3/4in., 2013.
3M Tegaderm Transparent Dressing FAQ Jan. 26, 2007.
3M Tegaderm Transparent Dressing I.F.U. 1999.
Centurion “Dressings and securement products” brochure. 2011.
Medline “Today's wound care treatments”, Jun. 2012.
Molnlychke Health Care “Mepore Film, formerly Mefilm”, 2007.
PCT/US2015/049517 filed Sep. 10, 2015 International Search Report and Written Opinion dated Jan. 21, 2016.
EP 15839400.7 filed Mar. 16, 2017 Extended European Search Report dated Mar. 16, 2018.
EP 15839400.7 filed Mar. 16, 2017 Partial European Search Report dated Mar. 16, 2018.
Related Publications (1)
Number Date Country
20160067106 A1 Mar 2016 US
Provisional Applications (1)
Number Date Country
62048747 Sep 2014 US